JADE BIOSCIENCES INC (JBIO) Stock Earnings & Estimates
NASDAQ:JBIO - US0080642061 - Common Stock
7.78 USD
+0.29 (+3.8%)
7.78 USD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||||||
| EBITDA YoY % growth | -3.33M | -8.89M -166.97% | -23M -158.72% | -53.17M -131.17% | -81.313M -52.93% | -74.014M 8.98% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -3.33M | -8.89M -166.97% | -23.02M -158.94% | -53.24M -131.28% | -81.409M -52.91% | -74.296M 8.74% | N/A -29.35% | N/A -4.01% | N/A -39.29% | N/A 81.17% | N/A -2.68% | N/A -2.70% | N/A -2.73% | N/A -2.74% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -73.85 -28.69% | -100.80 -36.49% | -85.40 15.28% | N/A 95.80% | N/A 37.11% | N/A -14.48% | N/A -4.94% | N/A -13.18% | N/A | N/A | N/A |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.47 97.62% | -0.52 92.24% | -0.57 81.87% | -0.61 29.43% | -0.57 -22.27% | -0.62 -20.61% |
| Revenue Q2Q % growth | ||||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -20.264M -18.43% | -22.44M -250.46% | -23.97M -607.71% | -26.01M 6.36% | -28.05M -38.42% | -31.11M -38.64% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.86 97.14% | -0.44 | -0.42 | -94.83% |
| Q1 2025 Q2Q % growth | -3.15 89.16% | -8.57 | 5.42 | 63.24% |
| Q4 2024 Q2Q % growth | -6.65 74.32% | -8.93 | 2.28 | 25.49% |
| Q3 2024 Q2Q % growth | -19.60 21.13% | -20.80 | 1.20 | 5.75% |
| Q2 2024 Q2Q % growth | -30.10 -13.16% | -29.35 | -0.75 | -2.57% |
| Q1 2024 Q2Q % growth | -29.05 -23.88% | -27.31 | -1.74 | -6.37% |
| Q4 2023 Q2Q % growth | -25.90 -21.31% | -25.26 | -0.64 | -2.52% |
| Q3 2023 Q2Q % growth | -24.85 -26.79% | -24.69 | -0.16 | -0.65% |
| Q2 2023 Q2Q % growth | -26.60 -55.10% | -24.85 | -1.75 | -7.05% |
| Q1 2023 Q2Q % growth | -23.45 -48.89% | -21.42 | -2.03 | -9.48% |
| Q4 2022 Q2Q % growth | -21.35 -74.29% | -22.06 | 0.71 | 3.20% |
| Q3 2022 Q2Q % growth | -19.60 -115.38% | -17.79 | -1.81 | -10.19% |
| Q2 2022 Q2Q % growth | -17.15 97.94% | -16.23 | -0.92 | -5.64% |
| Q1 2022 Q2Q % growth | -15.75 | -9.91 | -5.84 | -58.98% |
| Q4 2021 Q2Q % growth | -12.25 | -10.98 | -1.27 | -11.59% |
| Q3 2021 Q2Q % growth | -9.10 | -9.28 | 0.18 | 1.96% |
| Q2 2021 Q2Q % growth | -833.00 | -5.59 | -827.41 | -14,793.30% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -18.04% | -154.44% | 39.22% | 39.81% |
| Revenue | N/A | N/A | N/A | N/A |